Stockreport

Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving [Read more]